BDBM50010187 CHEMBL320288::[19-Acetylamino-4-carbamoyl-16-(3-guanidino-propyl)-7-hydroxymethyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaaza-cycloicos-10-yl]-acetic acid
SMILES: CC(=O)N[C@@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](CCCNC(N)=N)NC1=O)C(N)=O
InChI Key: InChIKey=GJXBXYYHINLHPM-NIFZNCRKSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50010187 (CHEMBL320288 | [19-Acetylamino-4-carbamoyl-16-(3-g...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | 5.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Research and Development Curated by ChEMBL | Assay Description Inhibition of canine platelet-rich plasma agregation induced by ADP | J Med Chem 34: 3114-25 (1991) BindingDB Entry DOI: 10.7270/Q2445KF0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Integrin alpha-IIb/beta-3 (Homo sapiens (Human)) | BDBM50010187 (CHEMBL320288 | [19-Acetylamino-4-carbamoyl-16-(3-g...) | PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 3.27E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals Research and Development Curated by ChEMBL | Assay Description Inhibition of canine platelet-rich plasma agregation induced by ADP | J Med Chem 34: 3114-25 (1991) BindingDB Entry DOI: 10.7270/Q2445KF0 | |||||||||||
More data for this Ligand-Target Pair |